Pharmacological agents in the treatment of venous disease: an update of the available evidence.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Vascular Pharmacology

• Publication date

  2009-06-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/157016109788340758PMID 19601855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease.

  2008cited by this paper
• Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg.

  2008cited by this paper
• O-(β-Hydroxyethyl)-Rutosides Systemic and Local Treatment in Chronic Venous Disease and Microangiopathy: An Independent Prospective Comparative Study

  2008cited by this paper
• 5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-(β-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry

  2008cited by this paper
• Randomized, Double Blind, Placebo-Controlled Clinical Trial to Evaluate the Lymphagogue Effect and Clinical Efficacy of Calcium Dobesilate in Chronic Venous Disease

  2008cited by this paper
• Pathogenesis of primary chronic venous disease: Insights from animal models of venous hypertension.

  2008cited by this paper
• Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial

  2007cited by this paper
• Interventions for varicose veins and leg oedema in pregnancy.

  2007cited by this paper
• Rapid Relief of Signs/Symptoms in Chronic Venous Microangiopathy With Pycnogenol®: A Prospective, Controlled Study

  2006cited by this paper
• Interventions for leg edema and varicosities in pregnancy. What evidence?

  2006cited by this paper
• Venoruton® vs Daflon®: Evaluation of Effects on Quality of Life in Chronic Venous Insufficiency

  2006cited by this paper
• Comparison of Pycnogenol® and Daflon® in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study

  2006cited by this paper
• Clinical efficacy of horsechestnut seed extract in the treatment of venous ulceration.

  2006cited by this paper
• Daflon 500 mg and Venous Leg Ulcer: New Results From a Meta-Analysis

  2005influential reference
• Relationships Between Symptoms and Venous Disease: The San Diego Population Study

  2005cited by this paper
• Phlebotonics for venous insufficiency.

  2005cited by this paper
• Relationships between symptoms and venous disease: the San Diego population study.

  2005cited by this paper
• Revision of the CEAP classification for chronic venous disorders: consensus statement.

  2004cited by this paper
• Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France.

  2004cited by this paper
• Venous hypertension, inflammation and valve remodeling.

  2004cited by this paper
• Calcium Dobesilate for Chronic Venous Insufficiency: A Systematic Review

  2004cited by this paper
• Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study.

  2003cited by this paper
• Chronic Venous Insufficiency: Worldwide Results of the RELIEF Study

  2002cited by this paper
• The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study.

  2002cited by this paper
• Efficacy and Safety of a Butcher’s Broom Preparation (Ruscus aculeatus L. Extract) Compared to Placebo in Patients Suffering from Chronic Venous Insufficiency

  2002cited by this paper
• Oxerutins (Venoruton®): Efficacy in Chronic Venous Insufficiency

  2002cited by this paper
• Stenotrophomonas maltophilia Endocarditis: A Systematic Review

  2002cited by this paper
• Deleterious effects of white cells in the course of skin damage in CVI.

  2002cited by this paper
• Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing.

  2002cited by this paper
• A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease.

  2002cited by this paper
• Clinical Evaluation of the Efficacy and Safety of Calcium Dobesilate in Patients with Chronic Venous Insufficiency of the Lower Limbs

  2002cited by this paper
• Horse chestnut seed extract for chronic venous insufficiency.

  2002cited by this paper
• Treatment of venous ulcers with pentoxifylline: a 6-month randomized, double-blind, placebo controlled trial.

  2002cited by this paper
• Deleterious effects of white cells in the course of skin damage in CVI.

  2002cited by this paper
• Prevalence and Risk Factors of Chronic Venous Insufficiency

  2001cited by this paper
• Clinical and Hemodynamic Outcomes in Patients with Chronic Venous Insufficiency After Oral Micronized Flavonoid Therapy

  2001cited by this paper
• RELIEF Study: First Consolidated European Data

  2000cited by this paper
• Micronized Purified Flavonoid Fraction and the Treatment of Chronic Venous Insufficiency: Microcirculatory Mechanisms

  2000cited by this paper
• Oral pentoxifylline for treatment of venous leg ulcers.

  2000cited by this paper
• RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids.

  2000cited by this paper
• Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot study.

  2000cited by this paper
• Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo‐controlled trial

  1999cited by this paper
• Symptoms of varicose veins

  1999cited by this paper
• Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers

  1999cited by this paper
• Socio-economic impact of chronic venous insufficiency. An underestimated public health problem.

  1998cited by this paper
• Placebo-Controlled Trial of Naftazone in Women with Primary Uncomplicated Symptomatic Varicose Veins

  1997cited by this paper
• Venous Elasticity After Treatment with Daflon 500 mg

  1997cited by this paper
• Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.

  1996cited by this paper
• Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration.

  1996cited by this paper
• Thrombocythemic Erythromelalgia, Primary Erythermalgia, and Secondary Erythermalgia: Three Distinct Clinicopathologic Entities:

  1994cited by this paper
• Controlled studies of Daflon 500 mg in chronic venous insufficiency.

  1994cited by this paper
• Evaluation of a New Venoactive Micronized Flavonoid Fraction (S 5682) in Symptomatic Disturbances of the Venolymphatic Circulation of the Lower Limb: A Double-Blind, Placebo-Controlled Study

  1994cited by this paper
• Randomised trial of oral aspirin for chronic venous leg ulcers.

  1994cited by this paper
• Transcutaneous Oxygen Tension Measurement in Patients with Chronic Arterial Obstructive Disease: Reliability and Long-Term variability of the Method

  1994cited by this paper
• Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency.

  1994cited by this paper
• Randomised trial of oral aspirin for chronic venous leg ulcers

  1994cited by this paper
• Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.

  1994cited by this paper
• Oxerutins in the prevention of recurrence in chronic venous ulceration: Randomized controlled trial

  1991cited by this paper
• A long term treatment with a venotropic drug. Results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency.

  1989cited by this paper
• Clinical evaluation of a venotropic drug in man. Example of Daflon 500 mg.

  1988cited by this paper
• Vascular Surgical Society of Great Britain and Ireland

  1984cited by this paper

• Adherence to Pharmacological Treatment in Chronic Venous Disease: Results of a Real-World, Prospective, Observational Cohort Study

  2025cites this paper
• Problems associated with the ATC system of drug classification.

  2025cites this paper
• Naturally occurring prenylated flavonoids from African Erythrina plant species

  2025cites this paper
• The nasal cycle rhythm based customized nonpharmacological intervention for chronic venous insufficiency and its complications: A case report

  2025cites this paper
• Relatório de estágio

  2025influential citation
• Ovarian hyperstimulation syndrome: an overview and prevention approaches

  2024cites this paper
• Innovative Approaches and Future Directions in the Management and Understanding of Varicose Veins: A Systematic Review.

  2024cites this paper
• Factors Influencing Venous Remodeling in the Development of Varicose Veins of the Lower Limbs

  2024cites this paper
• Chronic Venous Disease and Its Intersections With Diabetes Mellitus.

  2023cites this paper
• The Effect of Troxerutin Intraperitoneal Consumption on the Symptoms of Morphine Withdrawal Syndrome in Male Mice

  2023cites this paper
• The Effect of Troxerutin Consumption on the Symptoms of Morphine Withdrawal Syndrome in Male Mice

  2023cites this paper
• Design of an Herbal Preparation Composed by a Combination of Ruscus aculeatus L. and Vitis vinifera L. Extracts, Magnolol and Diosmetin to Address Chronic Venous Diseases through an Anti-Inflammatory Effect and AP-1 Modulation

  2023influential citation
• Cardioprotective Properties of Phenolic Compounds: A Role for Biological Rhythms

  2022cites this paper
• Formulation, Development, and In-Vitro Evaluation of a Film-Coated Tablet Containing a Flavonoid Diosmin and Hesperidin Combination

  2022cites this paper
• Strategies and challenges in treatment of varicose veins and venous insufficiency

  2022cites this paper
• Chronic venous disease. Part 2: diagnosis and treatment

  2022cites this paper
• Potential of Vasoprotectives to Inhibit Non-Enzymatic Protein Glycation, and Reactive Carbonyl and Oxygen Species Uptake

  2021cites this paper
• Venoactive Drugs, Summary of the Clinical Trials and Guidelines

  2021cites this paper
• Diosmin Inhibits Glioblastoma Growth through Inhibition of Autophagic Flux

  2021cites this paper
• Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management

  2021cites this paper
• Development of an Active Compression System for Venous Disease

  2020cites this paper
• SELF-MEDICATION PRACTICES AMONG THE PATIENTS WITH CHRONIC VENOUS DISEASE

  2020cites this paper
• Ameliorating effect of troxerutin in unilateral ureteral obstruction induced renal oxidative stress, inflammation, and apoptosis in male rats

  2020cites this paper
• Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency.

  2020cites this paper
• Draft Revision of Clinical Practice Guidelines for Varicose Veins -Treatment-

  2020cites this paper
• Troxerutin affects the male fertility in prepubertal type 1 diabetic male rats

  2019cites this paper
• The Significance of Pain in Chronic Venous Disease and its Medical Treatment.

  2019cites this paper
• Farmacijos specialistų vaidmuo dalyvaujant lėtinio venų nepakankamumo prevencijos ir gydymo procese Kauno mieste.

  2019influential citation
• The Seriousness of Chronic Venous Disease: A Review of Real-World Evidence

  2019cites this paper
• Efficacy and Safety of Daflon® in the Treatment of Idiopathic Epistaxis

  2019cites this paper
• AVURT: aspirin versus placebo for the treatment of venous leg ulcers - a Phase II pilot randomised controlled trial.

  2018cites this paper
• Cost-Effectiveness of Current and Emerging Treatments of Varicose Veins.

  2018cites this paper
• Chronic venous insufficiency – pathogenesis, diagnosis and pharmacological treatment. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part II

  2018cites this paper
• 14 – Venoactive Drugs

  2017cites this paper
• Transcriptomic analysis of gene expression in mice treated with troxerutin

  2017cites this paper
• Effect of Pycnogenol on the Healing of Venous Ulcers.

  2017cites this paper
• Venoactive Drug Therapy On Treatment Of Venous Ulcer

  2017cites this paper
• Diosmin versus cabergoline for prevention of ovarian hyperstimulation syndrome

  2017cites this paper
• Troxerutin, a bioflavonoid, improves oxidative stress in blood of streptozotocin-induced type-1 diabetic rats

  2017cites this paper
• Systematic investigation and molecular modelling of complexation between several groups of flavonoids and HP-β-cyclodextrins

  2017cites this paper
• Insuffisance veineuse chronique

  2016cites this paper
• Congenital Choroid Plexus Papilloma Following Treatment with Phlebotonic during Pregnancy

  2016cites this paper
• A multicenter review of epidemiology and management of varicose veins for national guidance

  2016cites this paper
• [Linee guida flebo-linfologiche SIF-SICVE 2016 della Società Italiana di Flebologia e della Società Italiana di Chirurgia Vascolare ed Endovascolare].

  2016cites this paper
• Wound healing and treating wounds: Differential diagnosis and evaluation of chronic wounds.

  2016cites this paper
• A consensus statement – part I. Recommendations for the management of chronic venous disease (CVD) in India and the key role of primary care doctors

  2016cites this paper
• Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration

  2016cites this paper
• Chronisch-venöse Insuffizienz

  2016cites this paper
• Wound healing and treating wounds: Chronic wound care and management.

  2016cites this paper
• The Use of the Venoprotector Calcium Dobesilate for the Treatment of Chronic Venous Diseases

  2016cites this paper
• Re: 'Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)'.

  2016cites this paper
• Pharmacologic treatment to improve venous leg ulcer healing.

  2016cites this paper
• Beneficial Effect of Troxerutin on Diabetes-Induced Vascular Damages in Rat Aorta: Histopathological Alterations and Antioxidation Mechanism

  2015cites this paper
• Regulation of vascular endothelial genes by dietary flavonoids: structure-expression relationship studies and the role of the transcription factor KLF-2.

  2015cites this paper
• Unfallbedingtes postthrombotisches Syndrom in der ärztlichen Begutachtung

  2015cites this paper
• Relatório de estágio profissionalizante no Club de Golf de Miramar

  2015cites this paper
• Relatório de Estágio Profissionalizante

  2015influential citation
• Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS).

  2015cites this paper
• Effect of Micronized Purified Flavonoid Fraction Therapy on Endothelin-1 and TNF-α Levels in Relation to Antioxidant Enzyme Balance in the Peripheral Blood of Women with Varicose Veins.

  2015cites this paper
• A systematic review of the efficacy and tolerability of hydroxyethylrutosides for improvement of the signs and symptoms of chronic venous insufficiency

  2015cites this paper
• Benefits of micronized purified flavonoid fraction PAGE 95 in the reduction of symptoms after operation for hemorrhoidal disease

  2014cites this paper
• The effect of troxerutin on lipid peroxidation and tissue injury induced by myocardial ischemia reperfusion injury in diabetic rat

  2014cites this paper
• Drugs acting on the cerebral and peripheral circulations

  2014cites this paper
• Effect of troxerutin on insulin signaling molecules in the gastrocnemius muscle of high fat and sucrose-induced type-2 diabetic adult male rat

  2014cites this paper
• Summaries of recent phlebological abstracts

  2014cites this paper
• A Systematic Review of the Efficacy of Centella asiatica for Improvement of the Signs and Symptoms of Chronic Venous Insufficiency

  2013cites this paper
• Micronised purified flavonoid fraction alleviates the carbon tetrachloride-induced hepatic injury

  2013cites this paper
• Quantitative proteomics analysis of varicose veins: Identification of a set of differentially expressed proteins related to ATP generation and utilization

  2013cites this paper
• Treatment of chronic venous disease with flavonoids: recommendations for treatment and further studies

  2013cites this paper
• Design, analysis, testing, and evaluation of a prosthetic venous valve

  2013cites this paper
• Inhibition of Angiotensin-Converting Enzyme Activity by Flavonoids: Structure-Activity Relationship Studies

  2012cites this paper
• Neuroprotective and hepatoprotective effects of micronized purified flavonoid fraction (Daflon®) in lipopolysaccharide-treated rats.

  2012cites this paper
• Management of varicose veins and venous insufficiency.

  2012cites this paper
• progression of chronic venous disease : have we progressed ?

  2012cites this paper
• Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins.

  2011cites this paper
• Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions.

  2011cites this paper
• Chapter 14 – Venoactive Drugs

  2011cites this paper
• Ca2+-Dependent Contraction by the Saponoside Escin in Rat Vena Cava. Implications in Venotonic Treatment of Varicose Veins

  2011cites this paper
• Antioxidant therapy: current status and future prospects.

  2011cites this paper
• The role of endovenous thermal ablation in the treatment of varicose veins

  2011cites this paper
• Author ' s personal copy Pharmacological Treatment of Primary Chronic Venous Disease : Rationale , Results and Unanswered Questions

  2011cites this paper
• Farmacologia de drogas vasoativas

  2010cites this paper
• Epidemiology and aetiology of C4–6 disease

  2010cites this paper
• Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells

  2010cites this paper
• ‘New’ approaches to venous congestion

  2010cites this paper
• 13 – Traitement médicamenteux des varices

  2010cites this paper
• Chronic administration of troxerutin protects mouse kidney against D-galactose-induced oxidative DNA damage.

  2010cites this paper
• Venous Hypoxia: A Poorly Studied Etiological Factor of Varicose Veins

  2010cites this paper
• Flavonoid combinations cause synergistic inhibition of proinflammatory mediator secretion from lipopolysaccharide-induced RAW 264.7 cells Omar A. HarasstaniSaidi MoinChau Ling ThamChoi Yi Liew • Norazren IsmailRevathee RajajendramHanis H. HarithZainul A. Zakaria • Azam S. MohamadMohamad R. SulaimanD

  2010cites this paper
• The forgotten burden of deep venous disease

  2010cites this paper
• Pharmacology of vasoactive drugs

  2010cites this paper
• Pharmacological treatment in patients with C4, C5 and C6 venous disease

  2010cites this paper
• Endothelial barrier protection by natural compounds

  2009cites this paper
• Evaluation of the efficacy of the addition of Diosmin to cabergoline for the prevention of ovarian hyperstimulation syndrome in high-risk women undergoing assisted reproductive technology

  year unknowncites this paper